These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
308 related items for PubMed ID: 25520857
41. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression. Pronina IV, Loginov VI, Burdennyy AM, Fridman MV, Senchenko VN, Kazubskaya TP, Kushlinskii NE, Dmitriev AA, Braga EA. Gene; 2017 Mar 10; 604():1-8. PubMed ID: 27998789 [Abstract] [Full Text] [Related]
42. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Lee KH, Lotterman C, Karikari C, Omura N, Feldmann G, Habbe N, Goggins MG, Mendell JT, Maitra A. Pancreatology; 2009 Mar 10; 9(3):293-301. PubMed ID: 19407485 [Abstract] [Full Text] [Related]
44. Silencing of miR-1247 by DNA methylation promoted non-small-cell lung cancer cell invasion and migration by effects of STMN1. Zhang J, Fu J, Pan Y, Zhang X, Shen L. Onco Targets Ther; 2016 Mar 10; 9():7297-7307. PubMed ID: 27942223 [Abstract] [Full Text] [Related]
45. Co-expression of laminin β3 and γ2 chains and epigenetic inactivation of laminin α3 chain in gastric cancer. Ii M, Yamamoto H, Taniguchi H, Adachi Y, Nakazawa M, Ohashi H, Tanuma T, Sukawa Y, Suzuki H, Sasaki S, Imai K, Shinomura Y. Int J Oncol; 2011 Sep 10; 39(3):593-9. PubMed ID: 21617852 [Abstract] [Full Text] [Related]
46. A microRNA DNA methylation signature for human cancer metastasis. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, Gallagher WM, Eccles SA, Croce CM, Esteller M. Proc Natl Acad Sci U S A; 2008 Sep 09; 105(36):13556-61. PubMed ID: 18768788 [Abstract] [Full Text] [Related]
47. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L, He X, Li S, Sun R, Xiang Q, Ren G, Xiang T. Int J Oncol; 2018 Sep 09; 53(3):961-972. PubMed ID: 29956735 [Abstract] [Full Text] [Related]
48. Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer. Tsai KW, Hu LY, Chen TW, Li SC, Ho MR, Yu SY, Tu YT, Chen WS, Lam HC. Oncol Rep; 2015 Jan 09; 33(1):485-93. PubMed ID: 25394359 [Abstract] [Full Text] [Related]
49. Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition. Li LQ, Pan D, Chen Q, Zhang SW, Xie DY, Zheng XL, Chen H. Cell Physiol Biochem; 2018 Jan 09; 47(4):1533-1545. PubMed ID: 29940566 [Abstract] [Full Text] [Related]
50. Decitabine and Cisplatin are Synergistic to Exert Anti-Tumor Effect on Gastric Cancer via Inducing Sox2 DNA Demethylation. Zhu Z, Lin S, Wu X, Xu J, Li L, Ye W, Li J, Huang Z. Onco Targets Ther; 2021 Jan 09; 14():623-636. PubMed ID: 33519210 [Abstract] [Full Text] [Related]
51. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. Xie J, Tan ZH, Tang X, Mo MS, Liu YP, Gan RL, Li Y, Zhang L, Li GQ. World J Gastroenterol; 2014 Dec 14; 20(46):17439-47. PubMed ID: 25516656 [Abstract] [Full Text] [Related]
52. Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma. Oshimo Y, Oue N, Mitani Y, Nakayama H, Kitadai Y, Yoshida K, Chayama K, Yasui W. Int J Cancer; 2004 Jun 10; 110(2):212-8. PubMed ID: 15069684 [Abstract] [Full Text] [Related]
53. Aberrant DNA Methylation-Mediated FOXF2 Dysregulation Is a Prognostic Risk Factor for Gastric Cancer. Zhang C, Li YZ, Dai DQ. Front Mol Biosci; 2021 Jun 10; 8():645470. PubMed ID: 34568422 [Abstract] [Full Text] [Related]
54. Epigenetic silencing of miR-493 increases the resistance to cisplatin in lung cancer by targeting tongue cancer resistance-related protein 1(TCRP1). Gu Y, Zhang Z, Yin J, Ye J, Song Y, Liu H, Xiong Y, Lu M, Zheng G, He Z. J Exp Clin Cancer Res; 2017 Aug 31; 36(1):114. PubMed ID: 28859669 [Abstract] [Full Text] [Related]
55. Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer. Kang N, Choi SY, Kim YK, Yoo IeR, Han DH, Lee DS, Kim YS, Hong SH, Kang JH, Lee KY, Park JK, Sung SW, Park MS, Yim HW, Kim SJ, Park JY. Lung Cancer; 2015 Aug 31; 89(2):99-103. PubMed ID: 26101014 [Abstract] [Full Text] [Related]
56. The epigenetic silencing of LIMS2 in gastric cancer and its inhibitory effect on cell migration. Kim SK, Jang HR, Kim JH, Noh SM, Song KS, Kim MR, Kim SY, Yeom YI, Kim NS, Yoo HS, Kim YS. Biochem Biophys Res Commun; 2006 Oct 27; 349(3):1032-40. PubMed ID: 16959213 [Abstract] [Full Text] [Related]
57. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y. Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023 [Abstract] [Full Text] [Related]
58. Occurrence of HHIP gene CpG island methylation in gastric cancer. Song Y, Zuo Y. Oncol Lett; 2014 Nov 15; 8(5):2340-2344. PubMed ID: 25295121 [Abstract] [Full Text] [Related]
59. DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W. Cancer; 2005 Oct 15; 104(8):1609-19. PubMed ID: 16134180 [Abstract] [Full Text] [Related]
60. Aberrant methylation of miR-125b1 in gastric cancer: A case-control study. Raad M, Salehi Z, Sasani ST, Mashayekhi F, Aminian K, Koutenayi MH. Neoplasma; 2019 Jul 23; 66(4):603-608. PubMed ID: 30868893 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]